Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Modeling of cytotoxicity on so...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Modeling of cytotoxicity on some non- nucleoside reverse transcriptase inhibitors of HIV-1: role of physicochemical parameters

Modeling of cytotoxicity on some non- nucleoside reverse transcriptase inhibitors of HIV-1: role of physicochemical parameters

Bibliographic Details
Main Authors: B.K. Tiwari, A Thakur, M Thakur, N D Pandey, S S Narvi, P Sudele
Format: Article
Language:English
Published: Arkat USA, Inc. 2006-02-01
Series:ARKIVOC
Online Access:https://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/ark.5550190.0007.225
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/ark.5550190.0007.225

Similar Items

  • Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
    by: Esnouf, R, et al.
    Published: (1995)
  • Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
    by: N. S. Shastina, et al.
    Published: (2011-04-01)
  • Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    by: Valeria Famiglini, et al.
    Published: (2016-02-01)
  • Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV
    by: Daniel M. Himmel, et al.
    Published: (2020-06-01)
  • Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
    by: George W Rutherford, et al.
    Published: (2016-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs